Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Cardiff Oncology (CRDF) over the last 8 years, with Q3 2025 value amounting to $6.3 million.

  • Cardiff Oncology's Non-cash Items fell 2190.5% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 2190.5%. This contributed to the annual value of $4.7 million for FY2024, which is 1964006.94% up from last year.
  • According to the latest figures from Q3 2025, Cardiff Oncology's Non-cash Items is $6.3 million, which was down 2190.5% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Cardiff Oncology's Non-cash Items ranged from a high of $12.8 million in Q1 2025 and a low of $23926.0 during Q4 2023
  • For the 3-year period, Cardiff Oncology's Non-cash Items averaged around $6.3 million, with its median value being $6.2 million (2025).
  • In the last 5 years, Cardiff Oncology's Non-cash Items soared by 1964006.94% in 2024 and then tumbled by 2190.5% in 2025.
  • Over the past 3 years, Cardiff Oncology's Non-cash Items (Quarter) stood at $23926.0 in 2023, then soared by 19640.07% to $4.7 million in 2024, then skyrocketed by 33.93% to $6.3 million in 2025.
  • Its Non-cash Items was $6.3 million in Q3 2025, compared to $6.0 million in Q2 2025 and $12.8 million in Q1 2025.